117 related articles for article (PubMed ID: 12925146)
1. Interaction of leptin with gastric myofibroblast transdifferentiation in Helicobacter pylori-infected Mongolian gerbils: the effect of rebamipide.
Nakamura M; Akiba Y; Matsui H; Tsuchimoto K; Ishii H
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():99-105. PubMed ID: 12925146
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.
Higuchi K; Tanigawa T; Hamaguchi M; Takashima T; Sasaki E; Shiba M; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Watanabe T; Arakawa T
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():1-7. PubMed ID: 12925135
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
Hahm KB; Kim DH; Lee KM; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Joo HJ; Cho YK; Nam KT; Cho SW
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():24-38. PubMed ID: 12925138
[TBL] [Abstract][Full Text] [Related]
5. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
7. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
[TBL] [Abstract][Full Text] [Related]
8. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
[TBL] [Abstract][Full Text] [Related]
9. Expression of leptin in two-layered culture of gastric mucous cells and fibroblasts: effect of Helicobacter pylori attachment.
Nakamura M; Takahashi T; Matsumoto T; Akiba Y; Matsui H; Tsuchimoto K; Ishii H; Yamada H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():125-30. PubMed ID: 15298618
[TBL] [Abstract][Full Text] [Related]
10. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
[TBL] [Abstract][Full Text] [Related]
11. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
[TBL] [Abstract][Full Text] [Related]
12. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Fujioka T; Arakawa T; Shimoyama T; Yoshikawa T; Itoh M; Asaka M; Ishii H; Kuwayama H; Sato R; Kawai S; Takemoto T; Kobayashi K
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():146-52. PubMed ID: 12925153
[TBL] [Abstract][Full Text] [Related]
13. [The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract].
Yakovenko EP; Agafonova NA; Ivanov AN; Yakovenko AV; Aldiyarova MA; Volosheinikova TV; Grigoryeva YV; Soluyanova IP
Ter Arkh; 2016; 88(4):88-92. PubMed ID: 27070169
[TBL] [Abstract][Full Text] [Related]
14. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
[TBL] [Abstract][Full Text] [Related]
15. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
Kim J; Kim K; Lee JS; Kim SY; Kim KO; Kim YJ; Kwon KA; Park DK; Chung JW
Korean J Gastroenterol; 2018 Apr; 71(4):204-212. PubMed ID: 29684969
[TBL] [Abstract][Full Text] [Related]
16. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Keto Y; Ebata M; Okabe S
Nihon Yakurigaku Zasshi; 2001 Oct; 118(4):259-68. PubMed ID: 11680169
[TBL] [Abstract][Full Text] [Related]
18. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.
Du Y; Li Z; Zhan X; Chen J; Gao J; Gong Y; Ren J; He L; Zhang Z; Guo X; Wu J; Tian Z; Shi R; Jiang B; Fang D; Li Y
Dig Dis Sci; 2008 Nov; 53(11):2886-95. PubMed ID: 18288617
[TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
Talley NJ; Riff DS; Schwartz H; Marcuard SP
Aliment Pharmacol Ther; 2001 Oct; 15(10):1603-11. PubMed ID: 11564000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
